Hepatocellular Carcinoma Prevention by Aspirin: Are Platelets the Link?

Código QR

Hepatocellular Carcinoma Prevention by Aspirin: Are Platelets the Link?

Guardado en:

Detalles Bibliográficos
Autores principales:	Hans Dieter Nischalke, Alexandra Klüners, Jacob Nattermann, Thomas Berg, Christian P. Strassburg, Philipp Lutz
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	Diseases of the digestive system. Gastroenterology RC799-869
Acceso en línea:	https://doaj.org/article/5f021c0ef1794df1a96188aa95767c06
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Current and Emerging Tools for Hepatocellular Carcinoma Surveillance
por: Nia Adeniji, et al.
Publicado: (2021)

Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility
por: Ferrín G, et al.
Publicado: (2015)

The Ratio of Platelets to Lymphocytes Predicts the Prognosis of Metastatic Colorectal Cancer: A Review and Meta-Analysis
por: Jinming Wang, et al.
Publicado: (2021)

Percutaneous hepatic radiofrequency for hepatocellular carcinoma: results and outcome of 46 patients
por: Bertr, et al.
Publicado: (2015)

Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics
por: Dhanasekaran R, et al.
Publicado: (2012)

Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis C virus
por: Bruno S, et al.
Publicado: (2011)

Transarterial chemoembolization using iodized oil for unresectable hepatocellular carcinoma: perspective from multistep hepatocarcinogenesis
por: Yoshimitsu K
Publicado: (2014)

Value of albumin-bilirubin grade in predicting liver function changes and prognosis of hepatocellular carcinoma patients undergoing transarterial chemoembolization: A Meta-analysis
por: YU Weiming
Publicado: (2021)

Type I interferon receptor in peripheral blood mononuclear cells may predict response to intra-arterial 5-fluorouracil + interferon therapy for advanced hepatocellular carcinoma
por: Korenaga K, et al.
Publicado: (2011)

Mechanism of the inhibitory effect of ghrelin in sepsis
por: Asha Jacob, et al.
Publicado: (2010)

Therapeutic efficacy of lenvatinib in nonviral unresectable hepatocellular carcinoma
por: Tetsu Tomonari, et al.
Publicado: (2021)

Implementing Collaborative Care Management of Behavioral Health for Patients with Inflammatory Bowel Disease
por: Christine Beran, et al.
Publicado: (2021)

Impact of Diagnostic Delay on Disease Course in Pediatric Versus Adult-onset Patients with Ulcerative Colitis: Data from the Swiss IBD Cohort
por: Alain M. Schoepfer, et al.
Publicado: (2021)

Hybrid endoscopic mucosal resection and full-thickness resection for large colonic polyps harboring a small focus of invasive cancer: a case series
por: Jamie S. Chua, et al.
Publicado: (2021)

Diarrhoea and preadmission antibiotic exposure in COVID-19: a retrospective cohort study of 1153 hospitalised patients
por: Sebastian Tullie, et al.
Publicado: (2021)

Clinical approach to skin eruptions induced by anti-TNF agents among patients with inflammatory bowel diseases: insights from a multidisciplinary IBD-DERMA clinic
por: Henit Yanai, et al.
Publicado: (2021)

Leukocyte‐Derived High‐Mobility Group Box 1 Governs Hepatic Immune Responses to Listeria monocytogenes
por: Annika Volmari, et al.
Publicado: (2021)

Clinical Features and Outcomes of Primary Sclerosing Cholangitis in the Highly Admixed Brazilian Population
por: Mateus Jorge Nardelli, et al.
Publicado: (2021)

Impact of medical therapies for inflammatory bowel disease on the severity of COVID-19: a systematic review and meta-analysis
por: Mohammad Shehab, et al.
Publicado: (2021)

Impact of early cholecystectomy on the readmission rate in patients with acute gallstone cholangitis: a retrospective single-centre study
por: Bishnu Sapkota, et al.
Publicado: (2021)

Integrated real-time imaging system, ‘IRIS’, Kangaroo feeding tube: a guide to placement and image interpretation
por: Stephen Taylor, et al.
Publicado: (2021)

Risk of common infections in people with inflammatory bowel disease in primary care: a population-based cohort study
por: Peter M Irving, et al.
Publicado: (2021)

Persistence of immunity from 1 year of age after one or two doses of hepatitis A vaccine given to children in Argentina
por: Espul C, et al.
Publicado: (2012)

Stopping anti-TNF in CD remitters: pros and cons
por: Edouard Louis
Publicado: (2021)

DEDICATED PSYCHIATRY CLINIC FOR INFLAMMATORY BOWEL DISEASE PATIENTS HAS A POSITIVE IMPACT ON DEPRESSION SCORES
por: Kaleb Bogale, et al.
Publicado: (2021)

Serum anti-modified citrullinated vimentin antibody concentration is associated with liver fibrosis in patients with chronic hepatitis
por: Suad Abdeen, et al.
Publicado: (2011)

New-onset ascites as a manifestation of virologic relapse in patients with hepatitis C cirrhosis
por: Chua DL, et al.
Publicado: (2014)

Metabolic syndrome in chronic hepatitis C infection: does it still matter in the era of directly acting antiviral therapy?
por: Lim TR
Publicado: (2014)

Update on entecavir in the management of severe forms of Hepatitis B
por: Sacco R
Publicado: (2012)

CCR 3: Annual Meeting of the Clinical Research Development Unit of Shahid Rajaei Educational and Medical Center
por: Hossein Karim, et al.
Publicado: (2020)

Incidence of ‘new-onset’ constipation and associated factors during lockdown due to the COVID-19 pandemic
por: Bryan Adrian Priego-Parra, et al.
Publicado: (2021)

Organoid vs In Vivo Mouse Model: Which is Better Research Tool to Understand the Biologic Mechanisms of Intestinal Epithelium?
por: Shinya Sugimoto, MD, PhD, et al.
Publicado: (2022)

Rebuttal to: Organoid vs Mouse Model: Which is a Better Research Tool to Understand the Biologic Mechanisms of Intestinal Epithelium?
por: Jordi Guiu, PhD, et al.
Publicado: (2022)

CMGH: The year in review
por: Klaus H. Kaestner, PhD, MS, et al.
Publicado: (2021)

Contents
Publicado: (2021)

Form Follows Function for Local Immune Responses in Pancreatic Cancer
por: Anna L. Means, PhD
Publicado: (2021)

Myeloid Cell Mediated Immune Suppression in Pancreatic CancerSummary
por: Samantha B. Kemp, et al.
Publicado: (2021)

Cover 2 - Tertiary Lymphoid Structures: Hub for Pancreatic Cancer Immune Response
Publicado: (2021)

An Epigenetic Switch Between Differentiation and Proliferation in Hepatoblastoma
por: Jeffrey H. Albrecht, MD
Publicado: (2021)

Editorial Board
Publicado: (2021)